human hbsag elisa kit (Novus Biologicals)
Structured Review
Human Hbsag Elisa Kit, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 94/100, based on 4 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hbsag+elisa/HBsAg+ELISA+Kit+(Colorimetric)/pmc12856759-283-16-22
Average 94 stars, based on 4 article reviews
Images
Related Articles
Enzyme-linked Immunosorbent Assay:Article Title: A hepatitis B virus-derived peptide combined with HBsAg exerts an anti-HBV effect in an HBV transgenic mouse model as a therapeutic vaccine Article Snippet: .. For genotyping, primers SF, 5’-TTG ACA AGA ATC CTC ACA ATA CC-3’ and SR, 5’-GGA GGT TGG GGA CTG CGA AT-3’, and Article Title: A hepatitis B virus-derived peptide combined with HBsAg exerts an anti-HBV effect in an HBV transgenic mouse model as a therapeutic vaccine Article Snippet: .. For genotyping, primers SF, 5’-TTG ACA AGA ATC CTC ACA ATA CC-3’ and SR, 5’-GGA GGT TGG GGA CTG CGA AT-3’, and other:Article Title: Synthetic gRNA/Cas9 ribonucleoprotein targeting HBV DNA inhibits viral replication. Article Snippet: The presence of hepatitis B virus (HBV) covalently closed circular (ccc) DNA (cccDNA), which serves as a template for viral replication and integration of HBV DNA into the host cell genome, sustains liver pathogenesis and constitutes an intractable barrier to the eradication of chronic HBV infection.. The current antiviral therapy for HBV infection, using nucleos(t)ide analogues (NAs), can suppress HBV replication but cannot eliminate integrated HBV DNA and episomal cccDNA.. CRISPR/Cas9 is a powerful genetic tool that can edit integrated HBV DNA and minichromosomal cccDNA for gene therapy, but its expression and delivery require a viral vector, which poses safety concerns for therapeutic applications in humans. |

